Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Functional Role of Extracellular Matrix Proteins in Cancer. | Cancers (Basel) | 2022 | 35008401 | PubTator, text mining | PubMed |
| Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition. | J Biol Chem | 2022 | 34958800 | PubTator, text mining | PubMed |
| Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma. | EMBO Mol Med | 2022 | 34957688 | PubTator, text mining | PubMed |
| Expression and significance of SOX B1 genes in glioblastoma multiforme patients. | J Cell Mol Med | 2022 | 34953010 | PubTator, text mining | PubMed |
| Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants. | Kidney Int | 2022 | 34952098 | PubTator, text mining | PubMed |
| Targeting KRAS mutant lung cancer: light at the end of the tunnel. | Mol Oncol | 2022 | 34951114 | PubTator, text mining | PubMed |
| DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3. | JCI Insight | 2022 | 34941574 | PubTator, text mining | PubMed |
| Transgenerational effects on the fecundity and sperm proteome in rats exposed to a mixture of pyrethroids at doses similar to human consumption. | Chemosphere | 2022 | 34896426 | PubTator, text mining | PubMed |
| DNA methylation in childhood dental caries and hypomineralization. | J Dent | 2022 | 34875274 | PubTator, text mining | PubMed |
| The extracellular matrix of hematopoietic stem cell niches. | Adv Drug Deliv Rev | 2022 | 34838648 | PubTator, text mining | PubMed |
| Discovery of Pyrazolo[3,4-d]pyridazinone Derivatives as Selective DDR1 Inhibitors via Deep Learning Based Design, Synthesis, and Biological Evaluation. | J Med Chem | 2022 | 34821145 | PubTator, text mining | PubMed |
| Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis. | Acta Pharmacol Sin | 2022 | 34819618 | PubTator, text mining | PubMed |
| Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology. | Cancer Metastasis Rev | 2022 | 34716856 | PubTator, text mining | PubMed |
| Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting. | Liver Transpl | 2022 | 34664394 | PubTator, text mining | PubMed |
| LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis. | J Gene Med | 2022 | 34559933 | PubTator, text mining | PubMed |
| Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report. | Anticancer Drugs | 2022 | 34321419 | PubTator, text mining | PubMed |
| Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies. | J Matern Fetal Neonatal Med | 2022 | 33653202 | PubTator, text mining | PubMed |
| Tackling cisplatin resistance in ovarian cancer: what can we do? | Cancer Drug Resist | 2021 | 35582376 | PubTator, text mining | PubMed |
| Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer. | RSC Adv | 2021 | 35478899 | PubTator, text mining | PubMed |
| Inflammation and Myeloid Cells in Cancer Progression and Metastasis. | Front Cell Dev Biol | 2021 | 35127700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=39